Fmoc-D-His(Fmoc)-OH

Fmoc-D-His(Fmoc)-OH is a protected, chiral histidine derivative in which the D-stereocenter is retained at the amino acid backbone and both the alpha-amino functionality and the imidazole side chain are masked as Fmoc carbamates. The molecule contains two fluorenylmethoxycarbonyl (Fmoc) groups, providing orthogonal deprotection behavior under standard base-promoted conditions while keeping the imidazole nitrogen protected during peptide coupling. The presence of a carboxylic acid enables C-terminal activation and amide bond formation, whereas the dual Fmoc protection suppresses side-chain coordination and side reactions that can occur with unprotected histidine. The resulting protected amino acid building block is well-suited for controlled peptide assembly and downstream generation of histidine-containing sequences with defined stereochemistry and side-chain reactivity.

1. Protected Amino Acid Synthesis

Fmoc-D-His(Fmoc)-OH supports protected amino acid synthesis workflows by combining a carboxylic acid handle with dual Fmoc masking of the histidine imidazole and amino group. The D-configuration at the alpha carbon provides stereochemical control for chiral peptide construction, while the Fmoc carbamate groups stabilize the imidazole during coupling and prevent undesired nucleophilic participation. The compound can be employed as a direct peptide building block or as a protected intermediate for preparing histidine derivatives that require controlled deprotection sequencing. Downstream processing can generate D-histidine residues in peptides or peptidomimetic scaffolds while maintaining compatibility with Fmoc-based synthetic strategies.

2. Peptide Synthesis

Fmoc-D-His(Fmoc)-OH is used in Fmoc/tBu solid-phase peptide synthesis and related peptide assembly approaches where histidine side-chain protection is required for reliable coupling and sequence fidelity. The carboxyl group enables standard activation chemistry for amide bond formation, while the dual Fmoc groups keep both the backbone nitrogen and the imidazole side chain protected throughout chain elongation. Controlled base-mediated removal of Fmoc groups can be applied to expose reactive sites in a stepwise manner, allowing incorporation of D-histidine into peptides with minimized side reactions such as imidazole-mediated interference. The resulting D-histidine-containing peptides can then serve as substrates for biochemical assays, conformational studies, or synthetic optimization of peptide properties.

3. Peptidomimetics And SAR Studies

Fmoc-D-His(Fmoc)-OH can be applied to peptidomimetic construction and structure-activity relationship studies where histidine's imidazole functionality is required to tune binding, metal coordination, or protonation behavior. The protected imidazole reduces premature reactivity during synthesis, enabling incorporation into analogs that later undergo deprotection to reveal the side-chain for receptor interaction or physicochemical characterization. D-stereochemistry can be leveraged to probe stereochemical effects on conformation, stability, and molecular recognition in SAR workflows without altering the core functional motif. The compound therefore functions as a chiral, side-chain-controlled intermediate for generating histidine-containing libraries and analog panels.

4. Chemical Biology And Protein Engineering

Fmoc-D-His(Fmoc)-OH is suitable for chemical biology and protein engineering efforts that require site-specific introduction of D-histidine residues into peptide probes, protein fragments, or engineered binding domains. The protected amino acid format enables controlled incorporation into defined sequences while suppressing imidazole reactivity during synthesis and purification. Subsequent deprotection can reveal the imidazole for downstream conjugation chemistry, metal-binding studies, or interaction mapping with biomolecular targets. The stereodefined histidine residue supports studies of stereochemical recognition and can be used to generate sequence-precise constructs for mechanistic investigations.

5. Biomolecule Labeling

Fmoc-D-His(Fmoc)-OH can be employed in biomolecule labeling strategies that rely on installing a protected histidine side chain into a targeting peptide or labeling handle prior to activation steps. The dual Fmoc protection supports stable peptide synthesis and purification, while the histidine imidazole can be unveiled after assembly to participate in subsequent derivatization, coordination-based capture, or selective coupling schemes. The D-histidine stereochemistry provides an additional design parameter for controlling labeling stability and minimizing unintended enzymatic processing in labeling workflows. The compound thus serves as a chiral precursor for generating histidine-functional labeling reagents and peptide-based conjugates used in analytical and biochemical research.

6. Pharmaceutical Intermediate Preparation

Fmoc-D-His(Fmoc)-OH is relevant to pharmaceutical intermediate preparation and process chemistry for the manufacture of protected amino acid building blocks used in peptide-like active ingredient synthesis. The carboxylic acid and protected amine enable predictable conversion into activated coupling partners or direct incorporation into peptide intermediates under Fmoc-compatible manufacturing conditions. Dual Fmoc masking limits side reactions associated with free imidazole nucleophilicity, supporting consistent downstream transformations during scale-up of protected sequence fragments. The compound can therefore function as a stereochemically defined intermediate for producing D-histidine-containing peptide intermediates used in fine chemical synthesis and specialty manufacturing pipelines.

1. Emu oil in combination with other active ingredients for treating skin imperfections

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)